Gynecol Endocrinol 31(3):196201
Hormonal Modulation Retas unique ability to interact with multiple receptor types provides a framework for studying hormonal cross-talk, especially how GLP-1, GIP, and glucagon signaling affect one another in metabolic tissues
A large cardiovascular outcome trial in high-risk T2D patients treated with the GLP-1 analog liraglutide (LEADER) demonstrated impressive reductions in CV mortality (22%
For people with PCOS or insulin resistance, this can help regulate previously irregular cyclesbut it can also take time for your body to adjust
Novel small molecule analogs for advancing apelin receptor antagonism with enhanced plasma and microsomal stability
injections of 100 nmol kg 1 MK-801 ( n = 8 mice and n = 4 cages), 100 nmol kg 1 GLP-1 ( n = 8 mice and n = 4 cages), 100 nmol kg 1 GLP-1MK-801 ( n = 8 mice and n = 4 cages), calorie restriction (Cal